If you receive a letter or text advising you to shield for 12 weeks please adhere to this for your own safety. See list below.
At Very High Risk (Groups) for Shielding 12 weeks
People with a solid organ transplant such as a kidney or liver transplan
People with specific cancers:
People with cancer who are undergoing active chemotherapy or radical radiotherapy for lung cancer
People with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
People having immunotherapy or other continuing antibody treatments for cancer
People having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
People who have had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe COPD. See below. •
People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell) •
People on immunosuppression therapies sufficient to significantly increase risk of infection •
People who are pregnant with significant congenital heart disease • All patients on the following medications: Azathioprine, Mycophenolate (both types), Cyclosporin, Sirolimus, Tacrolimus.
IF shielding- Stay at home at all times and avoid any face-to-face contact for at least twelve weeks.
If you’re a patient at our practice you can now use the new NHS App, a simple and secure way to access a range of NHS services on your smartphone or tablet.
You can use the NHS App to check your symptoms and get instant advice, book appointments, order repeat prescriptions, view your GP medical record and more.
If you already use www.patientaccess.com you can continue to use it. You can use the NHS App as well.
For more information go to www.nhs.uk/nhsapp